Published in Science Advances · View the paper (DOI)
A recent study published in Science Advances found that baricitinib treatment significantly reduces mortality in COVID-19 patients with moderate to severe symptoms. The drug, commonly used for rheumatoid arthritis, was shown to block viral entry and reduce inflammation, leading to a 71% reduction in mortality rates.
Coverage from 2 institutions